Comments on: Association of a novel circulating tumor fraction DNA biomarker of treatment response monitoring and clinical outcomes in a real-world, diverse pan-cancer cohort treated with immunotherapy

Comments on: Association of a novel circulating tumor fraction DNA biomarker of treatment response monitoring and clinical outcomes in a real-world, diverse pan-cancer cohort treated with immunotherapy https://www.tempus.com/publications/association-of-a-novel-circulating-tumor-fraction-dna-biomarker-of-treatment-response-monitoring-and-clinical-outcomes-in-a-real-world-diverse-pan-cancer-cohort-treated-with-immunotherapy/ AI-enabled precision medicine Mon, 06 Nov 2023 17:01:20 +0000 hourly 1